Share this article
Share this article
ResearchAndMarkets.com s offering.
Global Preclinical Contract Research Organizations Market to Reach $6.9 Billion by 2027
Amid the COVID-19 crisis, the global market for Preclinical Contract Research Organizations estimated at US$ 4.3 Billion in the year 2020, is projected to reach a revised size of US$ 6.9 Billion by 2027, growing at a CAGR of 6.9% over the analysis period 2020-2027.
Toxicology Testing, one of the segments analyzed in the report, is projected to record a 6.7% CAGR and reach US$ 4.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bioanalysis & DMPK Studies segment is readjusted to a revised 7.8% CAGR for the next 7-year period.
Share this article
Share this article
DES MOINES, Iowa, April 1, 2021 /PRNewswire/ Navigate Wellbeing Solutions (Navigate) - a national employee engagement technology company is expanding resources for their clients with the launch of their
Ecosystem Partnership Program. This new program will provide Navigate clients with even more tools and resources around topics like mental health and fitness as well as an incentive and rewards tool that will help engage employees along their wellbeing journey.
Working with some of the industry s leading wellbeing experts, Navigate currently provides a variety of resources on a wide range of topics from mental health and finances to diversity and inclusion training – partnering with experts in the industry like Your Money Line - a financial advising service, All of Us - a platform that focuses on providing diversity and inclusion content, PsychHub - mental health resources, and Occuvax - tailored flu and vaccination clinics. Navigate s
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary
RADR
® artificial intelligence ( A.I. ) platform to transform oncology drug discovery and development, today announced a collaboration with Johns Hopkins Pediatric Oncology Division of The Sidney Kimmel Comprehensive Cancer Center and Dr. Eric Raabe, M.D., Ph.D. focused on Lantern s drug candidate LP-184 in the area of brain tumors, and specifically in
Atypical
Rhabdoid
Tumors ( ATRT ), an ultra-rare and fast-growing cancerous tumor of the brain that presents primarily in children. As we enriched our
RADR
® A.I. platform for additional cancer indications, we began to discover common molecular pathways that drive response to our drug candidate, LP-184, across multiple additional CNS cancers, stated Panna Sharma, President and CEO of Lantern Pharma. Chief among these newly identified CNS cancers was ATRT, an ultra-rare and fast-growing cancerous tumor of the brain tha
Blue Cross and Blue Shield of Minnesota Reports 2020 Financial Results
News provided by
Share this article
Share this article
EAGAN, Minn., April 1, 2021 /PRNewswire/ The Blue Cross and Blue Shield of Minnesota (Blue Cross) family of companies today announced audited financial results for 2020. The organization reported operating income of $128 million on $13.2 billion in total revenue, for an operating margin of less than one percent. A pre-tax net income of $244 million was largely driven by the recovery of federal government payments owed through an Affordable Care Act (ACA) program designed to offset health plan operating losses. Audited results for 2020 include the consolidated financial statements for businesses operating under Aware Integrated, Inc. (AII), a nonprofit corporation and parent organization.
Brightline Announces Additions to Growing Leadership Team
Pediatric Behavioral Health Care Company Welcomes Technology and Health Care Leaders
News provided by
Share this article
Share this article
PALO ALTO, Calif., April 1, 2021 /PRNewswire/ Brightline, the first comprehensive behavioral health solution built specifically to care for children, teens, and their families across a range of common challenges, has announced the addition of four new members to their executive leadership team.
The growing pediatric virtual behavioral health care company welcomed Haleigh Tebben as Chief Commercial Officer, Gary Alpert as Chief Strategy Officer & Head of Business Development, Zack Still as Chief Information Officer & Chief Security Officer, and James Fitzpatrick as Vice President, Commercial. The additions to the leadership team come as Brightline plans for expansion this year.